NCT01722201View on ClinicalTrials.gov

Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Fasting
Interventions
DRUG

Risperidone Tablet 1 mg

1 mg tablet once a day

DRUG

Risperidone

1 mg tablet once a day

Trial Locations (1)

Unknown

Accutest Research Lab (I) Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY